Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs corticosteroid injections plus exercise for chronic shoulder pain (rotator cuff tendinopathy)
2025-522700-24-00Phase 3Authorised
- Sponsor
- Biobizkaia Health Research Institute
- Start
- Oct 2025
- Countries
- 1
01
Overview
Phase 3, randomised trial of platelet-rich plasma in shoulder tendinopathy (2 arms), sponsored by Biobizkaia Health Research Institute. Primary endpoint: Functional improvement by Constant-Murley scale at 6 months. Planned start Oct 2025; status: authorised.
02
Drugs
platelet-rich plasma
03
Conditions
shoulder tendinopathy
Beyond the preview
Go deeper on 2025-522700-24-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-522700-24-00.